SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-604299
Filing Date
2016-05-26
Accepted
2016-05-26 16:25:01
Documents
7
Period of Report
2016-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d190683d8k.htm 8-K 16901
2 EX-1.1 d190683dex11.htm EX-1.1 172416
3 EX-5.1 d190683dex51.htm EX-5.1 11357
4 EX-99.1 d190683dex991.htm EX-99.1 6635
5 EX-99.2 d190683dex992.htm EX-99.2 6707
6 GRAPHIC g190683g0526151506870.jpg GRAPHIC 2163
7 GRAPHIC g190683g0526155448094.jpg GRAPHIC 1693
  Complete submission text file 0001193125-16-604299.txt   220990
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 161678472
SIC: 2836 Biological Products, (No Diagnostic Substances)